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Abstract
Hedgehog (Hh) morphogens play fundamental roles in development whilst dysregulation of Hh
signaling leads to disease. Multiple cell surface receptors are responsible for transducing and/or
regulating Hh signals. Among these, the hedgehog-interacting protein (HIP) is a highly conserved,
vertebrate-specific, inhibitor of Hh signaling. We have solved a series of crystal structures for the
human HIP ectodomain and Desert Hh in isolation, as well as Sonic and Desert Hh-HIP
complexes, with and without calcium. The interaction determinants, confirmed by biophysical
studies and mutagenesis, reveal novel and distinct functions for Hh zinc- and calcium-binding
sites; functions which appear common to all vertebrate Hhs. Zinc makes a key contribution to the
Hh-HIP interface while calcium prevents electrostatic repulsion between the two proteins, thus
playing a major modulatory role. This interplay of several metal-binding sites suggests a tuneable
mechanism for regulation of Hh signaling.
A handful of secreted growth factors and morphogens are responsible for almost all
developmental decisions during embryogenesis and, among these, Hedgehog (Hh) family
proteins are ubiquitous players in tissue growth, patterning and morphogenesis1,2.
Dysregulation of Hh signaling has pathological consequences, triggering developmental
defects3, neurodegenerative diseases4 and cancer5.
The Hh signaling pathway is broadly conserved in vertebrates and invertebrates, but the
number of Hh ligands has expanded during evolution (one Hh in Drosphila, and three in
mammals: Sonic hedgehog (Shh), Desert hedgehog (Dhh) and Indian hedgehog (Ihh))1.
Mature Hh proteins are derived from Hh protein precursors by auto-processing and lipid
attachment to generate a dually lipid-modified amino-terminal signaling domain (Hh-N)6.
These modifications facilitate the integration of Hh into multimeric lipoprotein particles7,8.
Hh constructs lacking the lipid attachment sites have the same receptor binding properties,
but their tissue distribution is impaired6,9.
The extracellular regulation of signaling is more complex in vertebrates than in
invertebrates. Transduction of Hh signals into cells is mediated by the two transmembrane
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receptors Smoothened and Patched (PTC)10. The interference hedgehog protein family
(Ihog in fly and CDO and BOC in human)11 and heparan sulphate proteoglycans (HSPG)12
act as crucial modulators in both vertebrates and invertebrates, while hedgehog-interacting
protein (HIP)13 and growth arrest-specific gene 1 (GAS 1)14 are vertebrate-specific.
HIP is an inhibitor of Hh signaling. It is attached to the cell surface by a C-terminal helix
and binds all three Hh ligands (Sonic, Indian and Desert Hh) with nanomolar affinity13.
Cells exposed to Hh up-regulate both PTC and HIP expression13. A secreted version of HIP
is also able to sequester Hh, thus interfering with Hh signaling15. HIP functions in cartilage
development13, normal nerve development16 and axon guidance17 and its expression is
altered in a variety of cancers18-21. Despite this wealth of functional data, the molecular
mechanisms underlying HIP function are still unknown. We therefore undertook an analysis
of the structural and binding characteristics of human HIP-Hh interactions.
RESULTS
Structure of the human HIP ectodomain
A series of HIP constructs were produced in mammalian HEK-293T cells (22, see methods
for details). The full-length ectodomain of human HIP (eHIP, 56-670) fragmented during
expression; mutation of the proteolytic recognition sequences (Arg189, Arg210 and Lys211
to alanine; eHIPS construct) or an N-terminal truncation of the first 213 amino acid residues
(eHIP∆N construct) resulted in proteolytically stable and homogeneous proteins (Fig. 1a).
The stabilized full-length ectodomain is dimeric whereas eHIP∆N is a monomer
(Supplementary Fig.1) suggesting a function for the N-terminal cysteine-rich domain in
mediating dimerisation, although we cannot rule out that dimerization might be a
consequence of mutagenesis.
Attempts to crystallize the stabilised ectodomain of HIP failed, but eHIP∆N yielded well-
ordered crystals. The structure was solved using selenomethionine-labeled protein for
phasing (Fig.1b). Refinement resulted in an R-factor of 20.1% (R-free: 23.9%) to 2.8 Å
resolution with two eHIP∆N molecules in the crystallographic asymmetric unit
(Supplementary Fig. 2). The eHIP∆N monomer is composed of an N-terminal 6-bladed β-
propeller domain (residues 214-583) linked to two epidermal growth factor (EGF) repeat
domains (residues 607-637 and 638-670, respectively) (Fig. 1c). The major atypical
characteristic of the HIP β-propeller is a large protrusion of two loops from blade 3 which
form an extensive negatively charged patch on the surface (Fig. 1d). Twenty eight residues
connect the β-propeller to the EGF repeats. This well-ordered linker (colored orange in Fig.
1b and c) stretches across the β-propeller (over blades 6, 1 and 2). Disulphides (Fig. 1c)
stabilising the linker (I, IV and VI) and the orientation of the first EGF repeat (II and VI) are
conserved in all known HIP receptors (Supplementary Fig. 3). This rigid arrangement forms
a structural unit; attempts to produce truncated forms of HIP lacking the first EGF repeat
failed (unpublished data). The EGF repeats have a linear, elongated conformation with the
C-terminus of the second EGF repeat pointing away from the β-propeller domain. The major
difference between the two HIP molecules in the asymmetric unit is the relative orientation
of the second EGF repeat (Supplementary Fig. 2) reflecting the flexibility between the EGF
domains. This hinge may provide a necessary degree of freedom in the membrane-proximal
region of the ectodomain (which is tethered to the cell surface only nine residues
downstream of the second EGF repeat).
Structure of the HIP-Shh complex
We next produced (Supplementary Fig. 4) the complex between eHIP∆N and the N-terminal
signaling domain of Shh (ShhN, a monomeric construct that lacks the lipid-modification
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sites) and determined its crystal structure to 3.2 Å resolution. The Hh ligand uses a surface
oriented away from its termini (which are lipid-modified in vivo) to interact with the two
distinctive loops (BL1 and BL2) protruding from blade 3 of the HIP β-propeller (Fig.1d,
Fig. 2a and b). Two disulphide bridges at the beginning and the end of blade 3 (disulphide
bridges II, III in Fig. 2a) stabilise the blade for Hh ligand reception whilst the C-terminal
EGF repeats and membrane proximal region of HIP are oriented away from the ligand-
binding site. The complex interface buries 840 Å2 of eHIP∆N and 759 Å2 of ShhN with a
surface complementarity score (sc) of 0.66, and consists of 13 potential hydrogen bonds,
157 non-bonded van-der-Waals contacts and one zinc ion, involving a total of 14 residues of
the HIP receptor and 20 residues of ShhN (Supplementary Fig. 3 and 5a).
Detailed interactions are depicted in Fig. 2c-f. In eHIP∆N, BL1 (residues 370-391,
harbouring a small α-helical segment) forms the major interaction interface inserting into
the Shh zinc-binding cavity (Fig. 2b and c). The carboxylate group of HIP-Asp383, located
at the tip of BL1, completes the coordination of the zinc-binding site, which is formed by
Shh residues His141, Asp148 and His183 (Fig. 2d). The presence of the zinc was verified by
coordination geometry23, X-ray absorption- and fluorescence scans and anomalous
scattering (Supplementary Fig. 6). Two calcium ions, coordinated by Shh residues Glu90,
Glu91, Asp96, Thr126, Glu127 and Asp130 (Fig. 2f), are also clearly visible in the electron
density maps (Supplementary Fig. 6d) and appear to play an important role in the
stabilisation of a Shh loop (Lys88-Gly94; discussed below). The second HIP loop
contributing to binding (BL2) interacts with a Shh surface patch adjacent to the zinc-binding
cavity forming three potential hydrogen bonds and several van-der-Waals contacts (Fig. 2e).
Importance of metal-binding sites for HIP-Hh interactions
Although the eHIP∆N-ShhN interface is relatively small and the surface complementarity
score is at the lower end of the scale for physiological protein-protein interactions, binding
constants in the nanomolar range were observed using both cell-based 13 and surface
plasmon resonance (SPR) experiments (Fig. 3a and b, Supplementary Fig. 7). HIP
ectodomain (including the N-terminal cysteine-rich dimerisation domain; Fig. 1a) and
eHIP∆N show similar Hh-binding behaviour, although the full-length form has somewhat
enhanced binding which may reflect its dimeric state (Fig. 3). For both HIP constructs the
presence of zinc in the Hh metal-binding site is crucial (Fig. 3). Addition of 10 mM EDTA
(a chelator for divalent cations) completely abolished Hh-binding (Fig. 3d) or, in the
presence of calcium, mutation of the zinc-coordinating HIP-Asp383 (Fig. 2c and d) to
arginine or alanine abolished or reduced Hh-binding by greater than 25-fold, respectively
(Fig. 3a). Thus the tight Hh-HIP interaction can be explained by the contribution of HIP to
the coordination of zinc in the Hh ligand metal-binding site (Fig. 2d). Hall et al. 24 first
identified zinc in the crystal structure of ShhN, and pointed out a similarity to the zinc-
containing active sites of some metalloproteases. Zinc appears to play a crucial structural
role, binding ShhN with very high affinity (Kd ≤ 100 pM)25, however, the HIP-Shh
structure reveals a second role. Zinc-binding is the key mediator of complex formation;
indeed, the zinc-binding site is not conserved in Drosophila (Supplementary Fig. 5a), which
correlates with the absence of HIP in flies.
The low affinity (Kd ≥ 100 μM,26) calcium-binding site (Fig. 2f) adopts the same
conformation as described by McLellan et al.26 and found to be important for Shh binding
to various cell-surface receptors. We confirmed this finding in SPR experiments where
addition of 2 mM calcium caused a marked increase of the Hh-HIP binding affinity (Kd
from 100 nM to 6 nM; Fig. 3a-c, Supplementary Fig. 7). However, our structure reveals that
neither the two calcium ions nor the loops coordinating them contribute specific interactions
to the complex interface suggesting a secondary role for the calcium ions in HIP-binding.
We therefore investigated the effect of calcium absence on the structure of Hh ligands and,
Bishop et al. Page 3
Nat Struct Mol Biol. Author manuscript; available in PMC 2010 January 01.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
subsequently, on Hh-HIP structures. In the previously published uncomplexed ShhN
structure24, in the absence of calcium, the side chains of Glu90, Glu91 are oriented towards
the solvent (Fig. 4a). To verify whether this applies to other Hh ligands, we solved crystal
structures of the N-terminal signaling domain of human Desert Hh (DhhN, equivalent to the
ShhN construct) with and without bound calcium. The overall architecture of DhhN,
including the zinc-binding site, closely matches ShhN (r.m.s.d 0.5 Å for 150 Cα atoms; Fig.
4a) as expected from the high degree of sequence identity (77%, Supplementary Fig. 5). The
conformations of the Glu90 and Glu91 side chains in the calcium-free forms of ShhN24 and
DhhN match, while for DhhN with calcium bound, these residues contribute to metal-
coordination and adopt the conformation observed in the ShhN-eHIP∆N complex (Fig. 4a,
Supplementary Fig. 8).
We produced, crystallized and solved the structures of ShhN-eHIP∆N and DhhN-eHIP∆N
complexes in the absence of calcium (Supplementary Fig. 4). The structures show that the
Hh residues contributing to the Hh-HIP interface are highly similar across family members
and vertebrate species (Fig. 4b, Supplementary Fig. 5), conserving the architecture of the
ligand-receptor interfaces (Fig. 4c, Supplementary Fig. 9). In the absence of calcium the Hh
loop Lys88-Gly94 becomes disordered, suggesting that calcium-binding is important to
prevent electrostatic repulsion between the negatively charged residues of Hh loop Lys88-
Gly94 and a negatively charged patch (formed by HIP residues Asp377, Glu380, Glu381,
Asp383) on the apposing HIP surface (Fig. 2f). In the presence of calcium, stabilisation of
the loop allows the side chains of HIP-Glu381 and Shh-Glu90 to contribute to the complex
by forming additional van-der-Waals interactions (Fig. 4d), consistent with the observed 20-
to 60-fold increase in affinity between Hh ligands and HIP under these conditions (Fig. 3a).
A previously reported structure of ShhN in complex with the third fibronectin type III
domain of CDO showed calcium to be essential for binding26 and the conformation of the
calcium-binding site is essentially identical to the ones we observed in the DhhN and ShhN-
eHIP∆N structures (Supplementary Fig. 8). A comparison of the Shh-HIP and Shh-CDO
complexes shows a partial overlap of the receptor-binding interfaces which includes residues
of the Shh loop Lys88-Gly94; however, HIP and CDO have very different orientations
relative to the Hh ligand (Fig. 4e). The Shh-CDO interface does not include direct
interactions with the zinc-binding site and is less extensive, in agreement with solution
binding assays: KdShh-Cdo = 1300 nM26 and KdShh-HIP = 6 nM (Fig. 3a). In our Shh-HIP and
Dhh-HIP complexes the zinc-binding site is crucial for complex formation and even in the
absence of calcium the Hh-HIP affinities are 10-times higher than that reported for the Shh-
CDO (Fig. 3a).
DISCUSSION
The structural similarity between the Hh zinc-binding site and the active site of zinc-
hydrolases strongly suggests that these classes of proteins are evolutionarily related.
However, alteration of Shh residues, which by analogy should be essential for hydrolytic
activity, did not impair signaling via PTC, thus ruling out a functional requirement for
enzymatic catalysis27. The fact that this site is not conserved in any Drosophila species
sequenced to date, although it is maintained in all other closely related Hh orthologues from
insects and other invertebrates (Supplementary Fig. 5), further suggests that it is not required
for the canonical signaling pathways such as PTC. Nevertheless, vertebrates appear to have
exploited the presence of this zinc-binding site to diversify the repertoire of Hh interacting
proteins to include the HIP receptor, thus introducing an additional level of regulation in this
signaling pathway.
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Mutations of Shh-His140 and -Cys183 (residues directly or indirectly involved in zinc-
chelation) cause holoprosencephaly (HPE) and further facial anomalies as well as cancer in
human patients28,29. The ShhN-CDO interaction appears to be zinc independent26 and, as
discussed above, Drosphila Hh lacks the zinc binding site. Although site-directed
mutagenesis of residues forming the zinc-binding site led to a marked decrease of Shh
potency in a cellular differentiation assay, it was not clear whether this effect was due solely
to a decrease in protein stability25. However, since functional activity was not completely
abolished, interactions with other vertebrate Hh receptors (e.g. PTC) may not be entirely
dependent on the presence of zinc. In contrast, zinc clearly plays a central role in Hh ligand-
binding to HIP, thus the zinc- and calcium-binding sites have distinct functions in defining
the specificities of Hh interactions with cell-surface receptors.
For the Hh-HIP interaction our results reveal a secondary role for the calcium-binding sites.
The local concentration of extracellular calcium is highly variable30, thus the occupancy of
the low affinity-binding site in Hh may vary. The juxtaposition of one metal-binding site,
which plays the lead role in protein-protein interaction, with additional sites, which
modulate the binding affinity, is strongly reminiscent of ligand-binding by the integrin
family of cell adhesion molecules. For example, the structure of the integrin αIIbβ3 –
fibrinogen γC peptide interface is centred on the integrin metal ion-dependent adhesion site
(MIDAS; a high affinity magnesium-binding site) but has direct contributions from the
adjacent to MIDAS (ADMIDAS) calcium-binding site31. In general, for the integrin system,
the MIDAS metal ion has been shown to have a direct role in ligand-binding while the
ADMIDAS metal ion has a regulatory function. Similarly, our results suggest that the
interplay between the zinc- and calcium-binding sites in vertebrate Hh ligands may allow
extracellular calcium concentration to play an important modulatory role.
Accession codes
Protein Data Bank: Atomic coordinates and structure factors of ShhN-eHHIP∆N (with and
without Ca2+), DHHN-eHHIP∆N, eHHIP∆N and DHHN (with and without Ca2+) have
been deposited with accession numbers 2WFX, 2WG4, 2WG3, 2WFT, 2WFR and 2WFQ,
respectively.
METHODS
Production of the human hedgehog-interacting protein HIP ectodomain
We cloned human HIP ectodomain constructs (GenBank NP_071920; eHIP: residues
56-670; eHIP∆N: residues 214-670) into the pHLsec vector22 and expressed these by
transient transfection in HEK-293T cells in the presence of kifunensine32. Proteins were
purified from dialysed conditioned medium by immobilised metal-affinity chromatography
and treated with endoglycosidase F132 to cleave glycosidic bonds of N-linked sugars.
Proteins were concentrated and further purified by size-exclusion chromatography in 10mM
HEPES, pH 7.5, 150 mM NaCl. Selenomethionine-labelled eHIP∆N (SeMet-eHIP∆N) was
produced as described previously22.
Production of ShhN and DhhN, and complex formation with HIP
The N-terminal signaling domain of mouse sonic hedgehog (residues 40-194, GenBank
NP_033196) was produced as described above although no kifunensine was used since
ShhN is not glycosylated. Mouse ShhN differs in only one residue to human ShhN (a
structurally conserved exchange of Thr68 to Ser) and most likely the structure of human
ShhN is essentially identical to that of the murine orthologue. DhhN (residues 39-194,
GenBank NP_066382) was cloned into the pET22b expression plasmid (Novagen) and
expressed in E. coli Rosetta(DE3)pLysS cells. Cultures were grown at 37 °C to an A600 of
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0.8, cooled to 20 °C, induced with 0.25 mM isopropyl-beta-D-thiogalactopyranoside (IPTG)
and then grown for ~15h before harvesting. Bacterial pellets were resuspended in 25 mM
sodium phosphate, pH 8.0, 500 mM NaCl, 1 mM β-mercaptoethanol and EDTA-free
protease inhibitor cocktail (Roche). Cells were broken using a Basic Z model cell disruptor
(Constant Systems) and fractionated by centrifugation (30,000 xg, 5 °C, 30 min). DhhN was
purified from the supernatant by immobilised metal-affinity chromatography and size-
exclusion chromatography in 10 mM HEPES, pH 7.5, 150 mM NaCl.
The eHIP∆N-ShhN and eHIP∆N-DhhN complexes were formed by mixing a molar ratio of
1.5:1 purified hedgehog ligand to eHIP∆N receptor, incubated for 1 h at room temperature
and purified by size-exclusion chromatography in 10 mM HEPES, pH 7.5, 150 mM NaCl,
with or without 2 mM CaCl2.
Crystallization and data collection
Prior to crystallization proteins were concentrated by ultrafiltration (eHIP∆N: 4 mg ml-1,
eHIP∆N-ShhN: 8 mg ml-1, eHIP∆N-DhhN: 10 mg ml-1; DhhN: 7 mg ml-1). Nano-litre
crystallization trials were set-up using a Cartesian Technologies robot (100 nl protein
solution plus 100 nl reservoir solution) in 96-well Greiner plates33, placed in a TAP
Homebase storage vault maintained at 295 K and imaged via a Veeco visualization system.
Native and selenomethionine-labeled eHIP∆N crystallized in 0.1 M Tris-HCl, pH 8.5, 3.5 M
potassium formate, the eHIP∆N-ShhN complex in 0.1 M sodium acetate, pH 4.6, 0.5 M
potassium thiocyanate, the eHIP∆N-DhhN in 1.4 M sodium/potassium phosphate, pH 5.0
and DhhN in 0.1 M Tris-HCl, pH 8.5, 0.2 M lithium sulfate, 0.2 M sodium thiocyanate, 30%
(w/v) PEG4000. For the DhhN-calcium complex, crystals were grown as above and
subsequently soaked for 5 h with 50 mM CaCl2 dissolved in reservoir solution.
Diffraction data were collected at 100 K, crystals being flash-cooled in a cryo N2 gas stream.
Prior to flash-freezing, crystals were treated with the appropriate cryo protectant solutions
(eHIP∆N: 0.1 M Tris-HCl, 4.5 M potassium formate; eHIP∆N-ShhN: perfluoropolyether oil
PFO-X125/03 (Lancaster Synthesis); eHIP∆N-DhhN and DhhN: 25% (v/v) glycerol in
mother liquor). Data were collected at beamline ID29 (native and selenomethionine-labeled
eHIP∆N (λ=0.9792), eHIP∆N-ShhN with calcium (λ=0.9762), eHIP∆N-DhhN (λ=0.9793)
and DhhN with calcium (λ=0.9762)) at the European Synchrotron Radiation Facility,
France, and at beamlines I02 (DhhN without calcium (λ=0.9507)) and I03 (eHIP∆N-ShhN
without calcium (λ=0.8900)) at the Diamond Light Source, UK. X-ray data were processed
and scaled with the HKL suite34. The program XPREP (http://www.bruker-nonius.com)
was used to calculate quality indicators and to merge data. Data collection statistics are
shown in Table 1.
Structure determination and refinement
The eHIP∆N crystal structure was determined by single anomalous dispersion (SAD)
analysis. The positions of 12 selenium atoms were determined by using SHELXD35. This
solution was input into AUTOSHARP36 for phase calculation, improvement and phase
extension using the high-resolution native data to 2.8 Å resolution. The resulting map was of
high quality and allowed tracing of the whole polypeptide chain. An initial model was built
automatically using RESOLVE37 and completed by hand using COOT38. Non-
crystallographic symmetry restraints were used to refine the model using the programs
BUSTER39, REFMAC40 and Phenix41.
The DhhN structures were solved by molecular replacement using PHASER42 with the
structure of mouse ShhN (PDB 1VHH,24) as search model. This solution was input into
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ARP/WARP43 for automated model building and manually adjusted and refined using
COOT38 and REFMAC40.
The eHIP∆N-ShhN complexes with and without calcium and the eHIP∆N-DhhN complex
were solved by molecular replacement using Phaser with the eHIP∆N structure and the
ShhN (PDB 1VHH,24) or DhhN as search models, respectively. The resulting electron
density maps were of high quality and allowed manual adjustment and refinement of the
complex structures using COOT38, BUSTER39, REFMAC40 and Phenix41.
Refinement statistics are given in Table 1, all data within the indicated resolution range were
included. Stereochemical properties were assessed by MOLPROBITY44 and
PROCHECK45. Ramachandran statistics are as follows (favoured/disallowed in %): ShhN-
eHIP∆N with calcium: 92.4/0, ShhN-eHIP∆N without calcium: 92.7/0, DhhN-eHIP∆N:
95.7/0.1, eHIP∆N: 93.0/0, DhhN with calcium: 96.3/0, DhhN without calcium: 96.3/0.
Superpositions were calculated using SHP46 and electrostatic potentials were generated
using APBS47. SC48 was used to calculate the surface complementarity scores. Buried
surface areas of protein-protein interactions were calculated using the PISA webserver
(http://www.ebi.ac.uk/msd- srv/prot_int/pistart.html).
Site directed mutagenesis
Mutations were generated by a two-step overlapping PCR using Pyrobest Polymerase
(Takara). PCR products were cloned into the pHLsec mammalian expression vector
resulting in protein constructs with a C-terminal hexa-histidine or with a C-terminal BirA
recognition sequence22. Mutant proteins were secreted at similar levels to the wildtype
eHIP∆N and ShhN (unpublished data). The stringent quality control mechanisms specific to
the mammalian cell secretory pathway ensure that secreted proteins are correctly folded49.
Multiangle Light Scattering (MALS)
MALS experiments were carried out using an analytical Superdex S200 10/30 column (GE
Heathcare) with online static light scattering (DAWN HELEOS II, Wyatt Technology, Santa
Barbara, CA), differential refractive index (Optilab rEX, Wyatt Technology) and Agilent
1200 UV (Agilent Techologies) detectors. Proteins used for MALS were fully glycosylated
and had previously been purified by size-exclusion chromatography and concentrated to
approximately 2 mg/ml. Data were analysed using the ASTRA software package (Wyatt
Technology).
Surface Plasmon resonance (SPR) binding studies
SPR experiments were performed using a Biacore T100 machine (GE Healthcare, Uppsala,
Sweden) at 25 °C in 10 mM HEPES, pH 7.5, 150 mM NaCl, 0.05% polysorbate 20 (v/v),
supplemented with 2 mM calcium chloride where indicated. All proteins were homogeneous
with full biological activity and underwent gel filtration in running buffer immediately
before use. Protein concentrations were determined from the absorbance at 280 nm using
calculated molar extinction coefficients. Proteins for surface attachment were enzymatically
biotinylated within an engineered C-terminal tag. The native membrane insertion topology
was recapitulated by attachment of 200-2000 response units (RU) of biotinylated protein to
surfaces on which 3000 RU of streptavidin were coupled via primary amines50.
Experiments with wild type proteins were performed in both orientations and with mutant
proteins in one orientation. The signal from experimental flow cells was corrected by
subtraction of a blank and reference signal from a mock or irrelevant protein coupled flow
cell. In all experiments analyzed, the experimental trace returned to baseline after each
injection (Fig. 3b-d, Supplementary Fig. 7) and data fit to a simple 1:1 Langmuir model of
binding. Kd values were obtained by nonlinear curve fitting of the Langmuir binding
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isotherm (bound = C*max/(Kd + C), where C is analyte concentration and max is the
maximum analyte binding) to the data using the Levenberg-Marquardt algorithm
implemented in the program Origin (Microcal Software, Northampton, MA).
Illustrations
Figures were produced using the programs PYMOL (www.pymol.org), Adobe Photoshop
(Adobe Systems) and Corel Draw (Corel Corporation).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Structure of the HIP ectodomain. (a) Schematic domain organization of the HIP receptor.
SP: signal peptide; L1, L2: interdomain linker regions; EGF1, EGF2: epidermal growth
factor repeat domains; Hx: membrane attachment helix. β-propeller blades are color-coded
and numbered. Proteolytic cleavage site residues Arg189 and Arg210, identified by N-
terminal sequencing, are highlighted. The crystallization construct (eHIP∆N) and the
stabilised full-length ectodomain construct (eHIPS) are shown. (b) Selenomethionine SAD-
phased and phase-extended electron density map (calculated to 2.8 Å, contoured at 1 σ) with
rainbow-colored Cα trace of eHIP∆N. (c) Ribbon diagram of eHIP∆N with color coding as
in a and b. The six blades of the β-propeller domain (each consisting of a 4-stranded β-
sheet) are numbered as in a. The eleven disulphide bridges are shown in black stick
representation and marked with Roman numerals. d, Electrostatic properties. eHIP∆N is
shown as solvent accessible surface colored by electrostatic potential contoured at +/− 10 kT
(red, acidic; blue, basic). The prominent negatively charged patch which interacts with Hh
ligands is marked with a dotted circle.
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Figure 2.
Structure of the Shh-HIP complex. (a) Cartoon representation of eHIP∆N (orientation, β-
propeller blade numbering, and color coding as in Fig. 1c) in complex with ShhN depicted
as solvent accessible surface (in orange). Disulphide bridges (II and III), stabilizing HIP β-
propeller blade 3, are highlighted (dotted circles). (b) Cartoon representation of the
eHIP∆N-ShhN complex. The two binding loops (BL1 and BL2) of HIP are labeled. The zinc
ion is shown in grey and the two calcium ions in violet. (c-f) Close up views of the Shh-HIP
interactions. eHIP∆N (green) and ShhN (orange) main chains are shown as coils. Residues
involved in complex interactions are drawn in stick representation (oxygen: red, nitrogen:
blue). The zinc ion is shown in grey and the calcium ions in violet. Potential hydrogen bonds
are marked as yellow dotted lines, interactions with the zinc ion as grey dotted lines and
with calcium as violet dotted lines. Contacts of HIP-BL1 with ShhN are shown in c, the
zinc-binding site is detailed in d, HIP-BL2 interactions are shown in e and the properties of
the calcium-binding site in f.
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Figure 3.
Binding properties of Hh-HIP interactions. (a) Table of binding constants (Kd) measured by
SPR between different HIP constructs and ShhN or DhhN, respectively. Data are expressed
as mean ± standard error. ND: not determinable. (b-d) Binding of the stabilized HIP
ectodomain (eHIPS) to ShhN. The left panels are representative sets of experimental
sensorgrams from typical equilibrium-based binding experiments, with reference
substraction. Different concentrations of ShhN were injected over surfaces coupled with
eHIP in the presence (b) or the absence (c) of calcium and in the presence of 10 mM EDTA
(d), respectively. For all injections the primary experimental traces reached equilibrium and
returned to baseline after the injection. The right panels are plots of the equilibrium binding
response (RU) from the sensorgrams as a function of ShhN concentration (0.5 to 5000 nM).
Each plot is derived from a different independent experiment, but within each plot, the three
curves are derived from a single series of injections of ShhN over a biosensor chip in which
three experimental surfaces have been coated with different amounts of eHIPS. This allowed
the use of global fitting to improve data averaging. Best-fit binding curves with a global fit
of the experimental data to a uniform Kd value are shown as colored lines.
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Figure 4.
Molecular determinants of Hh-receptor interactions. (a) Structural superpositions. DhhN
with calcium (slate) and without (magenta), and ShhN with calcium (orange) and without
(yellow; PDB 1VHH) are shown as coils. Zinc and calcium ions are depicted as spheres. The
close-up highlights loop Lys88-Gly94, Glu90 and Glu91 (stick representation) change
conformation upon calcium-binding. (b) ShhN solvent-accessible surface colored by residue
conservation (Supplementary Fig. 5). Hh-binding loops of HIP are shown in cyan. (c)
Comparison of ShhN- and DhhN-HIP complexes. ShhN surface is colored orange. Shh loop
Lys88-Gly94, ordered only in the calcium-bound ShhN-HIP, is highlighted in red. Hh-
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binding loops of HIP are shown as coils (ShhN-eHIP∆N with calcium: green; ShhN-
eHIP∆N without calcium: blue; DhhN-eHIP∆N without calcium - molecule 1: yellow,
molecule 2: cyan). A third ligand-binding loop of HIP (BL3) is observed in only one copy of
the DhhN-eHIP∆N asymmetric unit (dotted ellipse, see also Supplementary Fig. 9). (d)
Effects of calcium-binding. ShhN-eHIP∆N complexes are shown as coils (with calcium:
orange/green, without calcium: violet/blue). Spheres highlight HIP-Glu381 and Shh-Glu90.
Shh-loop Lys88-Gly94 is depicted as a dotted line. (e) Comparison of the Shh-HIP and Shh-
CDO (PDB 3D1M) complexes. Shh ligands are superimposed (HIP: green, CDO: blue, HIP-
complexed ShhN: orange, CDO-complexed ShhN: red). Metal ions are depicted as spheres.
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Table 1
Data collection and refinement statistics
SeMet-
eHIP∆N
Native
eHIP∆N
eHIP∆N-ShhN
with calcium
eHIP∆N-ShhN
without
calcium
eHIP∆N-
DhhN without
calcium
DhhN-
without
calcium
DhhN with
calcium
Data collection
Space group P3121 P3121 P3221 P3221 P212121 P212121 P212121
Cell dimensions
 a, b, c (Å) 101, 101, 309 101, 101, 306 89, 89, 171 88, 88, 172 102, 110, 144 41, 42, 84 40, 42, 84
 α, β, γ (°) 90, 90, 120 90, 90, 120 90, 90, 120 90, 90, 120 90, 90, 90 90, 90, 90 90, 90, 90
Resolution (Å) 20.0-3.5
(3.6-3.5)
20.0-2.8
(2.9-2.8)
20.0-3.2
(3.3-3.2)
20.0-3.15
(3.25-3.15)
20.0-2.6
(2.7-2.6)
30.0-1.85
(1.95-1.85)
40.0-1.95
(2.05-1.95)
Rsym (%) 12.9 (62.3) 11.5 (73.7) 18.7 (72.8) 20.9 (88.5) 18.4 (81.0) 12.9 (68.0) 11.8 (74.9)
I / σI 15.7 (3.4) 14.7 (3.4) 10.6 (2.5) 9.9 (2.8) 15.3 (2.7) 14.6 (4.5) 10.5 (2.6)
Completeness (%) 99.5 (99.7) 99.5 (99.9) 100 (100) 99.2 (99.8) 100.0 (100.0) 99.6 (99.7) 93.6 (91.8)
Redundancy 11.3 (8.1) 9.1 (8.9) 6.5 (6.7) 7.5 (7.8) 10.0 (10.1) 12.7 (12.0) 6.8 (6.5)
Refinement
Resolution (Å) 20.0-2.8
(2.86-2.80)
20.0-3.2
(3.35-3.20)
20.0-3.15
(3.35-3.15)
20.0-2.6
(2.67-2.60)
30.0-1.85
(1.90-1.85)
40.0-1.95
(2.00-1.95)
No. reflections 45399 (2611)a 16254 (1640)b 13191 (2559)b 48634 (3477)c 12205 (876)d 10413 (718)d
Rwork /Rfree 20.1 (29.7)/
23.9 (34.2)
24.1 (32.7)/
29.9 (38.5)
23.4 (28.9)/
29.2 (34.1)
22.7 (33.0)/
28.1 (40.2)
18.9 (23.8)/
22.9 (27.9)
18.2 (25.8)/
22.5 (30.0)
No. atoms
 Protein 6578 4465 4455 17348 2599 2609
 Zinc 0 1 1 2 1 1
 Calcium 0 3 0 0 0 2
 Water 38 0 0 135 104 96
B-factors
 Protein 81 75 63 38 32 32
 Zinc - 60 44 28 30 30
 Calcium - 73 - - - 46
 Water 60 - - 34 25 22
R.m.s. deviations
 Bond lengths (Å) 0.014 0.004 0.004 0.011 0.013 0.014
 Bond angles (°) 1.794 0.524 0.557 1.329 1.382 1.455
Values in parentheses are for highest-resolution shell.
a
The asymmetric unit contains two eHIP∆N molecules.
b
The asymmetric unit contains one eHIP∆N-ShhN complex.
c
The asymmetric unit contains two eHIP∆N-DhhN complexes.
d
The asymmetric unit contains two DhhN molecules.
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